EXPOSURE VIA SKIN CONTACT

This adverse event was reported 25941 times

These drugs are most commonly taken by patients reporting EXPOSURE VIA SKIN CONTACT:

# Drug Count
0 DUPILUMAB 16495
1 MEPOLIZUMAB 1614
2 BELIMUMAB 1029
3 INSULIN GLARGINE 943
4 SOMATROPIN 798
5 EVOLOCUMAB 756
6 ALBUTEROL SULFATE 591
7 ERGOCALCIFEROL 366
8 ADALIMUMAB-AATY 298
9 PREDNISONE 295
See all common drugs associated with EXPOSURE VIA SKIN CONTACT

EXPOSURE VIA SKIN CONTACT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 USTEKINUMAB-STBA 24 0.0647
1 PERFLUOROHEXYLOCTANE 133 0.0572
2 INSULIN GLARGINE AND LIXISENATIDE 203 0.0555
3 INFLIXIMAB-DYYB 141 0.0409
4 CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE 2 0.0333
5 BELIMUMAB 1029 0.0321
6 MEPOLIZUMAB 1614 0.0320
7 DUPILUMAB 16495 0.0318
8 BACITRACIN ZINC AND NEOMYCIN AND POLYMYXIN B SULFATE 2 0.0282
9 BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL 2 0.0278
See all drugs enriched for association with EXPOSURE VIA SKIN CONTACT